Clinical Trial Update: Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluating lactoferrin for preventing febrile neutropenia and sepsis in oncohematologic children receiving induction chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Febrile Neutropenia (FN), Sepsis | NA | Status: COMPLETED